A record of what Sumeet Bagadia said publicly, with the source. Not advice.
“Recommends buying Fortis Healthcare shares at ₹671.80, setting a stop loss at ₹648 and targeting ₹719. The stock exhibits a strong bullish trend with a robust bullish candle and a decisive breakout from its consolidation range of ₹673-₹687, supported by significant trading volumes.”
Sumeet Bagadia’s track record (trackable calls only): 1528 graded calls · 95% CI 32–37%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
Entry: ₹671.8, as stated.
Target ₹719, stop ₹648, as stated.
No time frame is stated, so it is tracked until a close reaches ₹719 or ₹648: there is no fixed window.
The stop ₹648 was reached on a close before the target ₹719. Miss.
The grader’s working: R3 TRADE_SETUP: entered ₹687 on 2025-04-02 (stated entry ₹673–687 zone, ZONE entry, filled); stop ₹648 breached at close ₹633.35 on 2025-04-07. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.